好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cocaine Use Associated with Bilateral Globus Pallidus Changes; Similar to Carbon Monoxide intoxication.
General Neurology
P5 - Poster Session 5 (5:30 PM-6:30 PM)
7-025

Broadening the differential for bilateral globus pallidus MRI T2 hyperintense lesions beyond  carbon monoxide poisoning.

Bilateral symmetric lesions of areas of the brain supplied by a perforating arterial branches (internal capsule, basal ganglia and thalamus) are rare and specifically bilateral globus pallidus lesions are even rarer.They have been associated with various conditions, but most commonly its a pathognomonic sign of carbon monoxide poisoning.There is not much evidence in the literature for the combination of drug abuse resulting in similar imaging presentation.


Case series of 5 patients seen in one academic hospital presenting with acute bilateral globus pallidus  lesions over six months.

 

All five patients were found unresponsive after illicit drug use and had abused cocaine, with other substances, and found to have bilateral globus pallidus lesions T2 intense on MRI. Most commonly, it was cocaine with opiates (3 patients), one with cocaine and levamisole, and one with cocaine only (though limited toxicology screen). Clinical presentations early in the course ranged from myoclonus to additional ischemic lesions causing cortical blindness,but all had some degree of cognitive impairment.

 

We found that use of cocaine, typically with other illicit drugs, can present a similar imaging presentation as would be seen in carbon monoxide poisoning. Mechanism may be from hypo ventilation and additional vasospasm selectively impacting the metabolically high demand basal ganglia and in particular globus pallidus, though etiology remains uncertain.

Authors/Disclosures
Muhammad Azeem, MD (University of Massachusetts Medical School)
PRESENTER
No disclosure on file
No disclosure on file
Muhammad Nagy, MBBCh, MSc (JFK Neuroscience institute (Neurology Department)) Dr. Nagy has nothing to disclose.
No disclosure on file
No disclosure on file
Nils Henninger, MD, PhD, FANA, FWSO (UMass Memorial Medical Center) Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. Dr. Henninger has stock in Voyager. Dr. Henninger has stock in Alnylam. Dr. Henninger has stock in Entrada. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics.
Kate Daniello, MD, FAAN (University of Massachusetts) Dr. Daniello has nothing to disclose.